SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001140361-22-005030
Filing Date
2022-02-14
Accepted
2022-02-14 06:05:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC13G/A brhc10033961_sc13ga.htm SC 13G/A 62255
  Complete submission text file 0001140361-22-005030.txt   63792
Mailing Address 605 THIRD AVENUE 38TH FLOOR NEW YORK NY 10158
Business Address 605 THIRD AVENUE 38TH FLOOR NEW YORK NY 10158 212-610-6100
Nikko Asset Management Americas, Inc. (Filed by) CIK: 0001480751 (see all company filings)

IRS No.: 941302123 | State of Incorp.: DE | Fiscal Year End: 0310
Type: SC 13G/A

Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Subject) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89486 | Film No.: 22624452
SIC: 2835 In Vitro & In Vivo Diagnostic Substances